JAMES FLINN, Ph.D.
Intellectual Property and Innovation Director
Dr. Flinn is an Australian Patent Attorney with more than 20 years of professional experience in building and managing IP portfolios, and joined Immutep in April 2017. He has worked extensively in both private practice and corporate patent practice, and prior to joining Immutep worked for GSK for seven years as Senior Patent Counsel where he managed the global patent portfolio of GSK’s dermatology business unit. He has also worked for two US-based pharmaceutical companies, a major Australian retailer, and a Melbourne based Patent Attorney firm. Prior to training and qualifying as a Patent Attorney, Dr. Flinn completed doctoral studies in peptide chemistry and structural biology at the University of Melbourne.